Pacific Biosciences
PACB
HK$9.88
Share price
-3.05%
Change (1 day)
-64.14%
Change (1 year)
Categories
Pacific Biosciences (PACB) - P/B ratio
P/B ratio as of March 2025 : 0.7467
According to Pacific Biosciences
's latest financial reports the company has a price-to-book ratio of 2.18469.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Pacific Biosciences - P/B ratio (from 2010 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 1.21 | -67.71% |
| 2023-12-31 | 3.74 | 13.86% |
| 2022-12-31 | 3.29 | -42.42% |
| 2021-12-31 | 5.71 | -60.58% |
| 2020-12-31 | 14.5 | 1.01% |
| 2019-12-31 | 14.3 | 47.03% |
| 2018-12-31 | 9.75 | 173.47% |
| 2017-12-31 | 3.56 | -14.28% |
| 2016-12-31 | 4.16 | -70.88% |
| 2015-12-31 | 14.3 | 35.39% |
| 2014-12-31 | 10.5 | 110.52% |
| 2013-12-31 | 5.01 | 473.94% |
| 2012-12-31 | 0.8730 | 8.91% |
| 2011-12-31 | 0.8016 | -73.32% |
| 2010-12-31 | 3.00 | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 5.53 | 640.46% | 🇺🇸 USA |
 | -0.1002 | -113.42% | 🇺🇸 USA |
 | 11.3 | 1,413.96% | 🇺🇸 USA |
 | 3.90 | 422.48% | 🇺🇸 USA |
 | 1.80 | 140.98% | 🇺🇸 USA |